USPTO serial 77628275
Reviewed by CopyMark Law Group
Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Xianyang Buchang Pharmaceutical Co., Ltd.
Xianyang City, CN
Other trademarks owned by Xianyang Buchang Pharmaceutical Co., Ltd.
Xianyang Buchang Pharmaceutical Co., Ltd.
Xianyang City, CN
Other trademarks owned by Xianyang Buchang Pharmaceutical Co., Ltd.
Xianyang Buchang Pharmaceutical Co., Ltd.
Xianyang City, CN
Other trademarks owned by Xianyang Buchang Pharmaceutical Co., Ltd.
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.
HEZE CITY, SHANDONG PROVINCE, CN
Other trademarks owned by SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.
SHANDONG BUCHANG PHARMACEUTICAL INCORPORATED COMPANY
HEZE CITY, SHANDONG PROVINCE, CN
Other trademarks owned by SHANDONG BUCHANG PHARMACEUTICAL INCORPORATED COMPANY
SHANDONG BUCHANG PHARMACEUTICAL CO., LTD.
HEZE CITY, SHANDONG PROVINCE, CN
Other trademarks owned by SHANDONG BUCHANG PHARMACEUTICAL CO., LTD.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Charles Ho
Charles Ho BYIP LTD.5465 Legacy Drive, Suite 650Plano, TX 75024United States| Class | Description | Status | First use |
|---|---|---|---|
| 005 | DIETARY SUPPLEMENTS; DIETETIC FOODS ADAPTED FOR MEDICAL USE; NUTRITIONAL SUPPLEMENTS; MEDICINAL MATERIALS FOR TRADITIONAL CHINESE MEDICINES, NAMELY, MEDICINAL HERBS IN DRIED OR PRESERVED FORM, MEDICINAL BARK AND ROOTS OF PLANTS, MEDICINAL FLOUR, MEDICINAL STARCH; MEDICINES FOR HUMAN PURPOSES FOR THE TREATMENT OF INSOMNIA, PULMONARY DISEASE, NEPHROPATHY, HEPATOPATHY, HEART DISEASE, GASTRIC DISEASES, GYNECOPATHY, DERMATOSIS, RHEUMATIC DISEASE, TRACHOMA, CONJUNCTIVITIS, PNEUMONIA, ASTHMA, ESOPHAGUS DISEASES, ENTERITIS, ANEMIA, HEPATITIS, CARDIOVASCULAR AND CEREBROVASCULAR DISEASE, RHEUMATIC ARTHRITIS, NEURAL ASTHMA, APOPLEXY, HIGH FEVER, CANCER, INFLUENZA, COUGH, FEBRIS, RUBELLA, INFANTILE PARALYSIS, DYSENTERY, IMPALUDISM, TONSILLITIS, LARYNGITIS, PHARYNGITIS, HEADACHE, SPRAIN, TRAUMA, BRUISE, ECZEMA AND DUODENUM ULCER; MEDICINAL HERBS, NAMELY, CHINESE MEDICINES, NAMELY, HERB SUPPLEMENTS IN THE FORMS OF DECOCTION, PILLS, DROPS, POWDER, OINTMENT, PELLETS AND CAPSULE FOR THE TREATMENT OF GYNECOPATHY, INSOMNIA, HEPATOPATHY, HEART DISEASE, GASTRIC DISEASES, DERMATOSIS, RHEUMATIC DISEASE, CARDIOVASCULAR AND CEREBROVASCULAR DISEASE, RHEUMATIC ARTHRITIS, APOPLEXY, HIGH FEVER, INFLUENZA, COUGH, FEBRIS, LARYNGITIS, PHARYNGITIS, HEADACHE, SPRAIN, TRAUMA, BRUISE, ECZEMA AND DUODENUM ULCER; MEDICINES FOR HUMAN PURPOSES, NAMELY, BIOLOGICAL PREPARATIONS FOR MEDICAL PURPOSES FOR THROMBUS DISSOLUTION, BIOLOGICAL PREPARATIONS FOR MEDICAL PURPOSES FOR EMPYROSIS TREATMENT, BIOLOGICAL PREPARATIONS FOR MEDICAL PURPOSES USED AS ADJUVANT OF VACCINE; DIETETIC FOODS ADAPTED FOR MEDICAL PURPOSES, NAMELY, ADDITIVES TO FOOD FOR IMPROVEMENT OF IMMUNITY, PREVENTION AND TREATMENT OF HYPERGLYCEMIA, REDUCTION OF BLOOD PRESSURE, SUPPLEMENT OF HUMAN MICROELEMENT; ROYAL JELLY FOR MEDICAL PURPOSES; DEPURATIVES, NAMELY, ALL PURPOSE CHEMICAL DISINFECTANT; SURGICAL TISSUES, NAMELY, SURGICAL GAUZE FABRIC, SURGICAL BANDAGES; FILLING FOR DENTAL HOLES; CANDY FOR MEDICAL PURPOSES; CHINESE MEDICINE BAG, NAMELY, KITS CONSISTING OF DRIED OR PROCESSED MEDICINAL HERBS; MEDICINE DELIVERY PILLOW, NAMELY, PILLOWS FILLED WITH DRIED OR PROCESSED MEDICINAL HERBS; MEDICINE HEALTH BAG IN THE NATURE OF KITS CONSISTING OF DRIED OR PROCESSED MEDICINAL HERBS, CHEMICAL MEDICINE for the treatment of pain, fever, inflammation, rheumatic, gout, neurological system diseases, psychotropic system diseases, cardiovascular system diseases, respirometric system diseases, digestive system disease, urinary system disease, blood system disease, endocrine system disease, immune system disease, skin disease, gynecologic disease and cancer, and mineral supplements, all sold as a unit; FIRST-AID KIT | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 18, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 18, 2023 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Sep 18, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 18, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 27, 2019 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Nov 27, 2019 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Nov 27, 2019 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Nov 26, 2019 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 17, 2019 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Sep 25, 2019 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Jun 15, 2019 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Aug 31, 2016 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Aug 31, 2016 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Aug 30, 2016 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 19, 2016 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| May 30, 2012 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Oct 13, 2010 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jun 15, 2010 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 30, 2010 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 30, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 20, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 19, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 12, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 12, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 29, 2010 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 2, 2009 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 2, 2009 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 2, 2009 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 15, 2009 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Sep 15, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 12, 2009 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Sep 12, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 12, 2009 | ALIE | ASSIGNED TO LIE | — |
| Sep 10, 2009 | PAPER RECEIVED | — | |
| Mar 11, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 11, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 11, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 5, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 12, 2008 | MDSC | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| Dec 11, 2008 | NWAP | NEW APPLICATION ENTERED | — |